With a strong Board and a wealth of technical and commercial experience NeuDrive’s team has been working in the ﬁeld of organic electronic materials for over 20 years.
Simon OgierChief Technology Officer & Director
Simon has built an international reputation in the field of OTFT. After completing his degree and PhD in Physics with Electronics and Instrumentation he gained industrial experience with Avecia and Merck before joining CPI as R&D Manager in 2007 where he helped establish the UK’s National Printable Electronics Centre and led the technical program that established the FlexOS™ OTFT technology. He is a member of the international standards committee for printable electronics IEC TC119. He joined NeuDrive as CTO in 2015.
Malcolm StewartChief Executive Officer & Director
After an early career in the speciality chemicals industry Malcolm has spent the last 15 years working in and with early stage technology businesses. He was Vice President of Avecia’s Displays materials business, Managing Director of Liverpool Ventures and Executive Chairman of Phoenix Chemicals. Prior to joining NeuDrive as CEO he was interim Director of Business Development for the National Printable Electronics Centre.
Ray Fisher Founder & Director
Ray was the ‘Chemistry World’ Entrepreneur of the Year in 2015, awarded in recognition of his innovation and entrepreneurship over 30 years working in chemistry related businesses. He founded Peakdale Molecular in 1992 growing it into a leading supplier of chemistry services to the international pharmaceutical industry. After selling Peakdale in 2014 he founded NeuDrive to take forward his vision for organic electronics. A Fellow of the Royal Society of Chemistry, Ray remains actively involved in NeuDrive’s material science research.
Chris has been involved with 40+ start-ups and five $80m+ exits. He is formerly Chairman of Health Enterprise East (NHS Innovation Hub); Founder of Synergix Health (Health company); a Partner with New Venture Partners (International VC); Founder and CTO of BT Brightstar (Corporate Venturing) and an Entrepreneur and former Head of Futures Research at BT (R&D). He has provided innovation and IP commercialization advice to major corporations including companies such as Origin Energy, VTT, Xerox and Swiss Post Dr. Winter holds a BA (Oxon, Biochemistry), a PhD (Physics), and Visiting Professorships at UCS, Brunel and Reading Universities
In over 20 years as an executive leader in the life sciences industry, Andrew Powell has participated in generating more than $20B in shareholder value through a series of successful transactions. He has worked with fast growing companies through transformative stages in their development, ultimately helping to create, and then execute, three of the largest biotech deals of the decade: the sale of Medivation to Pfizer; the sale of InterMune to Roche; and the sale of ImClone Systems to Lilly.
At the start of his career Mr. Powell spent several years with Baxter International, working on the ground to expand their business in multiple countries, and negotiating (and ultimately managing) more than a dozen ex-U.S. joint ventures in China and developing countries in Asia and Latin America.
He serves on the boards of Aclaris, Inc., a NASDAQ listed biotech company, Cure Network Ventures, , and Sciaderm, Inc. a start-up specialty pharma company.
Paul Joyce Director
Paul is Managing Partner of Ramsdens Solicitors, a leading Yorkshire based law firm. He is a director of companies in both the private and not for profit sector and was a director of Peakdale Molecular from 1998 to 2014 before joining NeuDrive’s board.
Christine Fisher Founder
After an early career with Ellis and Everard, Christine was Operations Director of Peakdale Molecular from 1996 to 2014. Christine is a Board member of Business Peak District having previously served on the Board of Derbyshire Economic Partnership. In addition to being an active member of the Board of Directors Christine is the NeuDrive Company Secretary.
Gerry EvansVP Business Development - USA
A veteran of the life sciences industry in the USA, Gerry has been both a founder and senior executive of VC backed technology businesses. He was the co-founder of BioLeap Inc a drug discovery company enabled by the next generation of computational fragment-based design technology and the CEO of Taltec Inc.
Thin, lightweight, dynamically flexible, rugged
Flexible OTFT technology will enable product designers to create a whole new range of device concepts and deliver exciting new product formats to the consumer. These will enhance the interface between the physical and digital world
Simon Ogier, Chief Technology Oﬃcer
As a successful entrepreneur I passionately believe that the fusion of electronics, chemistry and biology offers huge scope for innovation, business development and growth. I founded NeuDrive to exploit the opportunities this fusion creates.
Ray Fisher FRSC, Founder & Director
NeuDrive is focussed on working with its partners to successfully transfer OTFT technology into full scale commercial production in our customer’s facilities. Performance, reproducibility, uniformity and manufacturing yield are key metrics for our success.